(Q34187942)

31 July 2017

1 reference

title

Diagnostic and pathogenetic role of antineutrophil cytoplasmic autoantibodies (English)

1 reference

31 July 2017

0 references

1 reference

3

Anna Sedivá

1 reference

31 July 2017

Jirina Bartůnková

1

1 reference

PubMed ID

12672398

31 July 2017

Vladimír Tesar

series ordinal

2

1 reference

31 July 2017

1 February 2003

1 reference

31 July 2017

1 reference

31 July 2017

106

1 reference

31 July 2017

2

1 reference

31 July 2017

73-82

1 reference

Granulocyte-specific antinuclear factors in synovial fluids and sera from patients with rheumatoid arthritis

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovirus aetiology?

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Vasculitis and glomerulonephritis: a subgroup with an antineutrophil cytoplasmic antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Wegener's autoantigen decoded

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Antigen specificities and clinical distribution of ANCA in kidney diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

ANCA and associated diseases: immunodiagnostic and pathogenetic aspects

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Catalase and alpha-enolase: two novel granulocyte autoantigens in inflammatory bowel disease (IBD)

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Novel autoantigens of perinuclear anti-neutrophil cytoplasmic antibodies (P-ANCA) in ulcerative colitis: non-histone chromosomal proteins, HMG1 and HMG2

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Clinical and pathological classification of ANCA-associated vasculitis: what are the controversies?

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Anticytoplasmic autoantibodies: their immunodiagnostic value in Wegener granulomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA) in Wegener's granulomatosis: a predominant role for the IgG3 subclass of ANCA

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Nomenclature of systemic vasculitides. Proposal of an international consensus conference

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

ANCA-positive Churg-Strauss syndrome with renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Autoantibodies against bactericidal/permeability-increasing protein in patients with cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Bactericidal/permeability-increasing protein (BPI) is an important antigen for anti-neutrophil cytoplasmic autoantibodies (ANCA) in vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

ANCA in diseases other than systemic vasculitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Clinical significance of anti-neutrophil cytoplasmic antibodies (ANCA) in autoimmune liver diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Antineutrophil cytoplasmic antibodies in rheumatoid arthritis. Characterization and clinical correlations

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Antineutrophil cytoplasmic antibodies in rheumatoid arthritis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Prevalence and clinical significance of antikeratin antibodies and other serological markers in Lithuanian patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Characterisation of autoantibodies to neutrophil granule constituents among patients with reactive arthritis, rheumatoid arthritis, and ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Antineutrophil cytoplasmic antibodies in patients with early rheumatoid arthritis: an early marker of progressive erosive disease

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Antineutrophil cytoplasmic antibodies in juvenile chronic arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Prospective evaluation of the frequency and clinical significance of antineutrophil cytoplasmic and anticardiolipin antibodies in community cases of patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Neutrophil cytoplasmic antibodies (p-ANCA) in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Anti-neutrophil cytoplasmic antibodies (ANCA) in inflammatory bowel disease: characterization and clinical correlates

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Are anti-neutrophil cytoplasmic antibodies (ANCA) clinically useful in inflammatory bowel disease (IBD)?

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Invasive amoebiasis is associated with the development of anti-neutrophil cytoplasmic antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Subacute bacterial endocarditis with positive cytoplasmic antineutrophil cytoplasmic antibodies and anti-proteinase 3 antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Seroprevalence and disease association of antineutrophil cytoplasmic autoantibodies and antigens in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Spectrum of disease associated with anti-neutrophil cytoplasmic autoantibodies in pediatric patients

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Antineutrophil cytoplasmic antibodies in children.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Antineutrophil cytoplasmic autoantibodies (ANCA) in children with cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Antineutrophil cytoplasmic antibodies in children with inflammatory bowel disease: prevalence and diagnostic value

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Antineutrophil cytoplasmic antibodies, anti-Saccharomyces cerevisiae antibodies, and specific IgE to food allergens in children with inflammatory bowel diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Wegener granulomatosis in children and adolescents: clinical presentation and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Immunogenetic risk factors for anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

alpha1-Antitrypsin (AAT) deficiency and ANCA-positive systemic vasculitis: genetic and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Analysis of anti-neutrophil cytoplasmic antibodies (ANCA): frequency and specificity in a sample of 191 homozygous (PiZZ) alpha1-antitrypsin-deficient subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

A linkage disequilibrium between genes at the serine protease inhibitor gene cluster on chromosome 14q32.1 is associated with Wegener's granulomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Novel SNPs in the CD18 gene validate the association with MPO-ANCA+ vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

HLA class II specificities in vasculitis with antibodies to neutrophil cytoplasmic antigens

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Environmental trigger for anti-neutrophil cytoplasmic antibodies?

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Bronchoalveolar lavage analysis in Wegener's granulomatosis. A method to study disease pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Nasal carriage of staphylococcal infection in Wegener granulomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Autoimmunity to lysosomal enzymes: new clues to vasculitis and glomerulonephritis?

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

ANCA signaling: not just a matter of respiratory burst

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Antibodies to neutrophil granulocyte myeloperoxidase and elastase: autoimmune responses in glomerulonephritis due to hydralazine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Minocycline-induced autoimmune syndromes: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Evaluation of antineutrophil cytoplasmic antibody seroconversion induced by minocycline, sulfasalazine, or penicillamine

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Antineutrophil cytoplasmic antibodies and HLA class II alleles in minocycline-induced lupus-like syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

ANCA-associated diseases and silica exposure

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Silicon exposure and vasculitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

The role of metals in autoimmune vasculitis: epidemiological and pathogenic study

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Animal models of anti-neutrophil cytoplasmic antibody associated vasculitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Lessons from animal models of vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Wegener's granulomatosis in pregnancy--the therapeutic dilemma.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Interference of PR3-ANCA with the enzymatic activity of PR3: differences in patients during active disease or remission of Wegener's granulomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Cloning of cDNA for proteinase 3: a serine protease, antibiotic, and autoantigen from human neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Autoimmunity to polymorphonuclears: functional consequences of the binding of antibodies to membrane and cytoplasmic target antigens of polymorphonuclear leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Reactivity of antineutrophil cytoplasmic autoantibodies with mononuclear phagocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Antineutrophil cytoplasmic antibodies induce human monocytes to produce oxygen radicals in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Neutrophil priming and apoptosis in anti-neutrophil cytoplasmic autoantibody-associated vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Induction of biologically active antineutrophil cytoplasmic antibodies by immunization with human apoptotic polymorphonuclear leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Interleukin-1 in crescentic glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

In situ production of TNF-alpha, IL-1 beta and IL-2R in ANCA-positive glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Influence of Plasma Exchange on Serum Levels of Cytokines and Adhesion Molecules in ANCA-Positive Renal Vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Cytokines and adhesion molecules in renal vasculitis and lupus nephritis.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA)

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

The role of antineutrophil cytoplasmic antibody (c-ANCA) testing in the diagnosis of Wegener granulomatosis. A literature review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

[Manifestations of primary vasculitis in the ENT region]

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Methods for the detection of anti-neutrophil cytoplasmic antibodies. Recommendations for clinical use of ANCA serology and laboratory efforts to optimize the informative value of ANCA test results

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Detection of anti-neutrophil cytoplasmic antibodies under actual clinical testing conditions.

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Association between active Wegener's granulomatosis and anticytoplasmic antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Anti-neutrophil cytoplasmic antibodies and disease activity during long-term follow-up of 70 patients with systemic vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener's granulomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Rise in ANCA titer: to treat or not to treat

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

Leucocyte membrane expression of proteinase 3 correlates with disease activity in patients with Wegener's granulomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS1521-6616%2802%2900026-8

7 January 2021

10.1016/S1521-6616(02)00026-8

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

12672398